NewsBenzingaBMOキャピタルは、Gildan Activewearの投資判断「アウトパフォーム」を維持し、目標株価を64ドルに引き下げた BMOキャピタルは、Gildan Activewearの投資判断「アウトパフォーム」を維持し、目標株価を64ドルに引き下げた Benzinga 2026.10.26 17:37 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy on Aptiv, Lowers Price Target to $72 TD Cowen Maintains Buy on Apollo Global Management, Lowers Price Target to $136 TD Cowen Maintains Hold on American Well, Raises Price Target to $13 Barclays Maintains Overweight on Zebra Technologies, Raises Price Target to $432 Barclays Maintains Overweight on Waters, Raises Price Target to $530 Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $626
